LKT Labs

Biochemicals for Life Science Research

SCH-772984

SCH-772984

Product ID S0929
Cas No. 942183-80-4
Purity ≥97%
Product Unit SizeCostQuantityStock
1 mg $57.80 In stock
5 mg $157.50 In stock
10 mg $262.50 In stock
25 mg $472.50 In stock
Bulk Quote

Quicklinks

Description

SCH-772984 is an inhibitor of ERK1/2 that exhibits anticancer chemotherapeutic activity. This compound inhibits cell and tumor growth in a variety of models, including cells featuring B-Raf, NRAS, and KRAS mutations. In combination with the braf inhibitor vemurafenib, SCH-722984 shows efficacy against BRAF-mutant melanoma with innate or required resistance or non-BRAF mutant melanoma. It also exhibits antitumor efficacy in pancreatic cancer cells when combined with cucurbitacin B, a natural tetracyclic triterpene.

Product Info

Cas No.

942183-80-4
Purity

≥97%
Formula

C33H33N9O2
Formula Wt.

587.69
Chemical Name

(3R)-1-[2-oxo-2-[4-(4-pyrimidin-2-ylphenyl)piperazin-1-yl]ethyl]-N-(3-pyridin-4-yl-1H-indazol-5-yl)pyrrolidine-3-carboxamide
IUPAC Name

(3R)-1-[2-oxo-2-[4-(4-pyrimidin-2-ylphenyl)piperazin-1-yl]ethyl]-N-(3-pyridin-4-yl-1H-indazol-5-yl)pyrrolidine-3-carboxamide
Synonym

SCH-772984, SCH772984, SCH 772984
Solubility

DMSO 14 mg/mL warmed (23.82 mM) Water Insoluble Ethanol Insoluble

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

S0929 MSDS PDF
Info Sheet

S0929 Info Sheet PDF

References

Nissan MH, Rosen N, Solit DB. ERK pathway inhibitors: how low should we go? Cancer Discov. 2013 Jul;3(7):719-21. PMID: 23847348.

Morris EJ, Jha S, Restaino CR, et al. Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors. Cancer Discov. 2013 Jul;3(7):742-50. PMID: 23614898.

Wong D., Robert L, et al. Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanoma. Mol Cancer. 13:194 (2014). PMID: 25142146.

Zhou J., Zhao T., et al. Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, STAT3 and ERK signaling. 8(61):103167-81 (2017). PMID: 29262554.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • S176481

    Semaglutide

    GLP-1 agonist

    ≥95%
  • R0245

    Raltitrexed

    Folate analog; thymidylate synthase inhibitor.<...

    ≥98%
  • Z2268

    Z-FR-AMC

    Protease substrate.

    ≥95%
  • A2501

    AG-1517

    EGFR inhibitor.

    ≥98%
  • P2919

    L-Phenylalaninol

    Non-essential amino acid alcohol.

    ≥98%
  • B3200

    BI-2536

    PLK1 inhibitor.

    ≥98%
  • M1335

    Mdivi-1

    Quinazolinone; mitochondrial division inhibitor...

    ≥98%
  • M1679

    Methysticin

    Kavalactone originally found in Piper methystic...

    ≥98%
  • C4657

    Clotrimazole

    Imidazole; 14-α demethylase, H+/K+ ATPase, Na+...

    ≥97%
  • O1200

    Odanacatib

    Cathepsin K inhibitor.

    ≥99%
  • N344784

    N-Nitroso Valsartan

    Valsartan impurity

    ≥98%
  • C2802

    CH5132799

    p110α PI3K inhibitor.

    ≥98%
  • T698579

    Tropodithietic Acid

    Produced by various marine proteobacteria

    ≥99%
  • S3353

    Sinomenine Hydrochloride

    Alkaloid found in Sinomenium; acid-sensing ion ...

    ≥98%
  • C002045

    Oxazolidine Cabazitaxel

    Synthesis impurity

    ≥95%
  • M1677

    11-Methoxyyangonin

    Minor kavalactone originally found in Piper met...

    ≥98%
  • P2515

    3-Phenylpropyl Isothiocyanate

    Synthetic ITC.

    ≥98%
  • H1992

    Hexaconazole

    Triazole; demethylation inhibitor.

    ≥95%
  • G0180

    Gastrin I, human

    Endogenous peptide hormone involved in feeding ...

    ≥98%
  • C9779

    Cytisine

    Alkaloid found in Fabaceae family plants; α3β...

    ≥98%